Member Info for neilrich3

This explains the Director/consultant share purchases back in November.....this is when the penny dropped.

Maybe, but assuming that December was also £92million, international revenue not as high as I'd like.

Crackers when you consider what's likely going on behind the scenes.....product flying off the shelves, hopefully the company is having its best ever weeks right now, share price shall catch up eventually.

I'd agree, feel that phase 2 as envisaged last September shall be history.

Not sure what Novacyt as a company actually produce within France, we have some offices, but what do they do?

I'm pretty certain that Novacyt shall make an announcement, one way or another, before the weekend with regards to le variant breton, very hard to believe that this can not be detected by PCR, more likely that the French have been using the wrong tests.

Also, why have x1 Q32 when in reality x2 Q16 is likely to be even more efficient, would always have at least one machine on the go.

"q32 surely"

I'd imagine that there's no Q32 spare, all available having been taken up by the likes of the NHS.

Potentially more than one company interested in NCYT.....do love a bidding war!

#Scarediecat
I'd been think that in relation to the appointment of Guillermo Raimondo, former Executive Vice President Global Marketing, Sales & Communications at Siemens Healthineers Diagnostics. Having spent most of his career (26 years) with Siemens.

Does this put Siemens Healthineers in the frame?

Interesting that they should do this now, perhaps they have some massive news in the pipeline and Novacyt are positioning themselves to ensure that their announcements have maximum impact, not just for investors, but more importantly current and potential customers.

What would really cement things.....would be the DHSC phase 2, plus a very large international order....or two!

For all we know Blackrock might be purchasing shares within the market and offloading to a third party, likely to be a daily occurrence should this be the case and would explain the fluctuation with their holding.

Thanks, very interesting.....clearly Roche anticipate a return on their investment.....so much for those that harp on about 'post covid'

https://twitter.com/HarpurUk/status/1371203667127324677/photo/1

Antibiotic resistance is the biggest threat to global health and guess what....PCR testing is going to be a massively important tool going forward in the battle, however don't listen to me.
https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance

Also, Professor Sharon Pea**** is an expert within this field.
While traditional microbiology and microbial genome sequencing and genomics rely upon cultivated clonal cultures, early environmental gene sequencing cloned specific genes (often the 16S rRNA gene) to produce a profile of diversity in a natural sample. Such work revealed that the vast majority of microbial biodiversity had been missed by cultivation-based methods.[2]

Because of its ability to reveal the previously hidden diversity of microscopic life, metagenomics offers a powerful lens for viewing the microbial world that has the potential to revolutionize understanding of the entire living world.[3] As the price of DNA sequencing continues to fall, metagenomics now allows microbial ecology to be investigated at a much greater scale and detail than before. Recent studies use either "shotgun" or PCR directed sequencing to get largely unbiased samples of all genes from all the members of the sampled communities.

Yes, she's on a fixed term contract, however Mahim has a fantastic CV, clearly smashed her targets and I'd imagine formed some good customer relationships....she has talent, surly Novacyt should be bending over backwards ensuring that she remains a part of the team.

Sounds good, although don't understand why she's now 'looking for a new role' outside of Novacyt, that's my only concern. You'd have thought that the commission on £52 million would have been worth hanging about for and staying with NCYT.

Actually...it is not Iran, but Indonesia.

https://www.youtube.com/watch?v=o2hLPbzejos